Pharma Leader Series: Top 30 Pharmaceutical Contract Manufacturing Organisations (CMOS) 2016-2026
LONDON, October 6, 2016 /PRNewswire/ --
North America, Europe, Japan, India, China, Other Leading Developed Market API Manufacturers, API Manufacturing, FDF Manufacturing
In its updated report, visiongain provides revenues to 2026 for the world pharmaceutical contract manufacturing organisations (CMO) market.
This report also analyses leading companies in pharmaceutical contract manufacturing. The demand for outsourced drug production has grown rapidly in the past 10 years. The world market for pharma contract manufacturing was worth $61.6bn in 2015, having grown by more than 6% from 2014.
The new study predicts strong growth in that industry's revenue, reaching $84.0bn worldwide in 2020, with further expansion expected.
Our 317-page report provides 185 tables, 110 figures and analysis of 30 leading companies.
The content of each profile differs, depending on the organisation. In general, though, a profile gives you the following information:
• Overview of the company's contract manufacturing services and operations
• Analysis of recent financial performance - annual revenue for CMO services, including some data on operating profit and margins
• Assessment of developments - activities, acquisitions, production capacity, deals, new service offerings and collaborations
• SWOT analysis - a firm's strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2015 onwards
• Forecasting of pharmaceutical manufacturing revenue to 2026, as well as projected operating profit and margin for some companies.
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
Leading Pharmaceutical Contract Manufacturing Organisations profiled in this report:
• Catalent
• Patheon
• Baxter
• AbbVie
• Pfizer
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Fareva
• Aenova
• Famar
• Vetter
• Almac
• Delpharm
• Siegfried
• Corden
• Recipharm
• Aesica
• Nipro
• Daito
• Teva API
• Esteve Quimica
• Euticals
• Zhejiang Hisun Pharmaceuticals
• Zhejiang Huahai Pharmaceuticals
• Shandong Xinhua Pharmaceuticals
• Aurobindo Pharma
• Divis Laboratories
• Dr. Reddy's Laboratories
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
To request a report overview of this report please emails Sara Peerun at sara.peerun@visiongainglobal.com or call Tel: +44 (0) 20 7336 6100
Organisations Mentioned in this Report
Abbott Laboratories
Abic
AbbVie
Actavis
Adamas Pharmaceuticals
Aegerion
Aenova Group
Aesica Pharmaceuticals
Agence Nationale de sécurité du Médicament et des produits de santé (ANSM)
Agência Nacional de Vigilância Sanitária (ANVISA)
Agennix
Aguettant
AlgoNomics
Alliance Medical Products
Almac Group
Alpharma
Amgen
AMYRA Biotech
Andeno
Apexigen
Aptuit
Archimica
Arecor
ArGEN-X
Astellas
AstraZeneca
Athera Biotechnologies
Aurobindo Pharma
Avalanche Biotechnologies
Banner Life Sciences
BaroFold
Barr-Pliva
BASF
Baxter BioPharma Solutions
Bayer
BC Partners
Becton and Dickinson (BD)
Beijing Double-Crane Pharmaceutical
Bentley
Biocraft
Biogal
Biomedical Advanced Research and Development Authority (BARDA)
Bionomics
Biotest
BioWa
Boehringer Ingelheim
Bridgepoint Capital
Bristol-Myers Squibb
Britest
Canyon
Carbogen Amcis
Cardinal Health
Catalent
Celladon
Celldex Therapeutics
Celsion
CEVEC Pharmaceuticals
Chemtrix BV
China National Pharmaceutical Group (SInopharm)
Chirotech
Circadian Technologies
Cleveland BioLabs
Cobra Biomanufacturing
Companies House
CordenPharma
Corvette Pharmaceutical Services
Daiichi Sankyo
Daito
DecImmune Therapeutics
Delmas Perfusion
Delpharm
Divis Laboratories
DPx Holdings
Dr. Reddy's Laboratories
Dragenopharm Apotheker Püschl and Swiss Caps
Eclipse Therapeutics
Eindhoven University of Technology
Eisai
Eli Lilly
EmulTech
Esteve Química
Euro Vital Pharma
European Medicines Agency (EMA)
Euticals
Evonik Degussa
Excella
Exelixis
Famar
Fareva
Farmaprojects
Frazier Healthcare
Fuyang Xinghai Investment
Genentech
Générique Même Médicament (GEMME)
Genzyme
GSK
Corixa
Haupt Pharma
Health Canada
Hejiang Jiang Yuan Tang Biotechnology
Human Genome Sciences
ICI
Immune Pharmaceuticals
Immunomedics
Index Ventures
Indoco Remedies
Intellect Neurosciences
International Chemical Investors Group
Ivax API
Japanese Ministry of Health Labor and Welfare (MHWL)
Japanese Pharmaceutical and Medical Devices Agency (PMDA)
JK Pharmaceutical
JLL Partners
Johnson & Johnson (J&J)
Kadmon
Laboratoires Besins
Lanxess Corporation
LBO Italia Investimenti s.r.l
Lonza
Marinopoulos Group.
MedImmune
Merck KGaA
Merck Serono
Mesoblast
Molecular Partners
Moody's Corporation
Mylan
NIH CRM
Nipro Corporation
Novartis
Novasep
Novozymes
NPS
OctoPlus
OncoMed Pharmaceuticals
Opthea
Osiris Therapeutics
Otsuka Pharmaceutical
Pantec
Patheon
Perrigo
PFC
Pfizer
Pharmacia
Pharmacyclis
Pharmintraco
Piramal
Plantex
Poli Industria Chimica
Progenics Pharmaceuticals
Prosintex
R5 Pharmaceuticals
RAG AG
Ranbaxy Labs
Recipharm
Regeneus
Relthy Laboratórios
Relypsa
Respirics
Rexim
Roche
Royal DSM
Sandoz
Sanofi
Sanquin Blood Supply foundation
Sanwa Kagaku Kenkyusho
Schering
ScinoPharm
Seattle Genetics
Sentry BioPharma Services
Servier
Shandong Tianda Biological Pharmaceutica
Shandong Xinhua Pharmaceutical
Shanghai Pharmaceutical
ShangPharma
Shire
Sicor
Siegfried
Sigmar Italia
Silverfleet Capital
Sinochem
SkyePharma
Solvay
Sun Pharma
Supernus Pharmaceuticals
SurModics
Swedbank
Swedish Orphan Biovitrium AB (Sobi)
Synkem
Syntex
Synthon
Takeda
Temmler Group
Tessenderlo Group
Teva Pharmaceutical Industries
Theramax
Tianjin Tianyo Pharmaceuticals
Tianma Tianji
Tunitas Therapeutics
UCB
UK Health and Safety Executive
UK Medicines and Healthcare Products Regulatory Agency (MHRA)
UMN Pharma
UniQure
University College London (UCL)
University of Bradford
University of Durham
University of Leeds
US Food and Drug Administration (FDA)
Vetter Pharma
Vidara
ViroPharma
Vivante GMP Solutions
VTU Technology
West Pharma
Wockhardt
XOMA
Yiwu Huayi Investment
Zhangjiang Biotech & Pharmaceutical Base Company
Zhejiang Hisun Pharmaceutical
Zhejiang Huahai Pharmaceuticals
To see a report overview please email Sara Peerun on sara.peerun@visiongainglobal.com
Share this article